Evidence map›Paper›PMID 25808636›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

Impact and effectiveness of risk mitigation strategies on the insurability of nanomaterial production: evidences from industrial case studies.

Enrico Bergamaschi, Finbarr Murphy, Craig A Poland, Martin Mullins, Anna L Costa, Eamonn McAlea, Lang Tran, Syed A M Tofail

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Personalized Nanomedicine: A Revolution at the Nanoscale.Journal of personalized medicine · 2017
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Enrico BergamaschiDipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Parma, Parma, Italy.
Finbarr MurphyKemmy Business School, University of Limerick, Limerick, Ireland.
Craig A PolandInstitute of Occupational Medicine, Edinburgh, UK.
Martin MullinsKemmy Business School, University of Limerick, Limerick, Ireland.
Anna L CostaISTEC-CNR, Faenza (RA), Italy.
Eamonn McAleaKemmy Business School, University of Limerick, Limerick, Ireland.
Lang TranInstitute of Occupational Medicine, Edinburgh, UK.
Syed A M TofailMaterials and Surface Science Institute (MSSI), University of Limerick, Limerick, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Workers involved in producing nanomaterials or using nanomaterials in manufacturing plants are likely to have earlier and higher exposure to manufactured/engineered nanomaterials (ENM) than the general population. This is because both the volume handled and the probability of the effluence of 'free' nanoparticles from the handled volume are much higher during a production process than at any other stage in the lifecycle of nanomaterials and nanotechnology-enabled products. Risk assessment (RA) techniques using control banding (CB) as a framework for risk transfer represents a robust theory but further progress on implementing the model is required so that risk can be transferred to insurance companies. Following a review of RA in general and hazard measurement in particular, we subject a Structural Alert Scheme methodology to three industrial case studies using ZrO2 , TiO2 , and multi-walled carbon nanotubes (MWCNT). The materials are tested in a pristine state and in a remediated (coated) state, and the respective emission and hazard rates are tested alongside the material performance as originally designed. To our knowledge, this is the first such implementation of a CB RA in conjunction with an ENM performance test and offers both manufacturers and underwriters an insight into future applications.

Indexed as

IndustryEnvironmental ExposureHumansMetalsNanoparticlesNanostructuresNanotechnologyNanotubes, CarbonOccupational ExposureParticle SizeRisk AssessmentSafetyMetalsNanotubes, Carbon

Identifiers

PMID25808636
PMCPMC6680359

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.